New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Adding pembrolizumab to chemo improves survival in cervical cancer, finds study

Adding pembrolizumab to chemo improves survival in cervical cancer, finds study

by Elana GotkineFor women with persistent, recurrent, or metastatic cervical cancer, adding pembrolizumab to chemotherapy, with or without bevacizumab, is associated with improved overall and progress
Oncology January 23,2024
Adding pembrolizumab to chemo improves survival in cervical cancer, finds study

Adding pembrolizumab to chemo improves survival in cervical cancer, finds study

by Elana GotkineFor women with persistent, recurrent, or metastatic cervical cancer, adding pembrolizumab to chemotherapy, with or without bevacizumab, is associated with improved overall and progress
Oncology January 23,2024
Genomic sequencing panels to personalize cancer treatment beneficial in only 5% of the patients, finds study

Genomic sequencing panels to personalize cancer treatment beneficial in only 5% of the patients, finds study

byThe Spanish National Cancer Research CentreThe use of these panels following the recommended clinical criteria increases the efficacy of treatments and patient survival. Credit: underbau / CNI
Oncology January 23,2024
Genomic sequencing panels to personalize cancer treatment beneficial in only 5% of the patients, finds study

Genomic sequencing panels to personalize cancer treatment beneficial in only 5% of the patients, finds study

byThe Spanish National Cancer Research CentreThe use of these panels following the recommended clinical criteria increases the efficacy of treatments and patient survival. Credit: underbau / CNI
Oncology January 23,2024
Genomic screening can help detect thyroid cancer, finds study

Genomic screening can help detect thyroid cancer, finds study

byGeisinger Health SystemCredit: Pixabay/CC0 Public DomainPopulation-based genomic screening can facilitate early detection of medullary thyroid cancer (MTC) in patients with variants in the RET
Oncology January 23,2024
Genomic screening can help detect thyroid cancer, finds study

Genomic screening can help detect thyroid cancer, finds study

byGeisinger Health SystemCredit: Pixabay/CC0 Public DomainPopulation-based genomic screening can facilitate early detection of medullary thyroid cancer (MTC) in patients with variants in the RET
Oncology January 23,2024
Immune checkpoint blockade prior to surgery promising in multiple cancer types, finds study

Immune checkpoint blockade prior to surgery promising in multiple cancer types, finds study

byJohns Hopkins University School of MedicineThis graphic highlights the vast scientific research opportunities associated with neoadjuvant immune checkpoint blockade. Credit:Cancer CellTr
Oncology January 23,2024
Immune checkpoint blockade prior to surgery promising in multiple cancer types, finds study

Immune checkpoint blockade prior to surgery promising in multiple cancer types, finds study

byJohns Hopkins University School of MedicineThis graphic highlights the vast scientific research opportunities associated with neoadjuvant immune checkpoint blockade. Credit:Cancer CellTr
Oncology January 23,2024
Study finds 'startling' inequities in end-of-life opioid treatment

Study finds 'startling' inequities in end-of-life opioid treatment

byHarvard UniversityCredit: Unsplash/CC0 Public DomainOlder Black and Hispanic patients with advanced cancer are less likely than white patients to receive opioid medications for pain relief in
Oncology January 23,2024
Study finds 'startling' inequities in end-of-life opioid treatment

Study finds 'startling' inequities in end-of-life opioid treatment

byHarvard UniversityCredit: Unsplash/CC0 Public DomainOlder Black and Hispanic patients with advanced cancer are less likely than white patients to receive opioid medications for pain relief in
Oncology January 23,2024
Conspiracy believers more likely to endorse mythical causes of cancer, finds study

Conspiracy believers more likely to endorse mythical causes of cancer, finds study

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainPeople who believe in conspiracies, reject the COVID-19 vaccine, or prefer alternative medicine are more likely to endorse mythical caus
Oncology January 23,2024
Conspiracy believers more likely to endorse mythical causes of cancer, finds study

Conspiracy believers more likely to endorse mythical causes of cancer, finds study

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainPeople who believe in conspiracies, reject the COVID-19 vaccine, or prefer alternative medicine are more likely to endorse mythical caus
Oncology January 23,2024
Study finds younger kidney cancer survivors at significant risk for heart problems

Study finds younger kidney cancer survivors at significant risk for heart problems

byVirginia Commonwealth UniversityCredit: Pixabay/CC0 Public DomainNew research out of VCU Massey Cancer Center indicates that many adolescent and young adult kidney cancer survivors are at a si
Oncology January 23,2024
Study finds younger kidney cancer survivors at significant risk for heart problems

Study finds younger kidney cancer survivors at significant risk for heart problems

byVirginia Commonwealth UniversityCredit: Pixabay/CC0 Public DomainNew research out of VCU Massey Cancer Center indicates that many adolescent and young adult kidney cancer survivors are at a si
Oncology January 23,2024
COVID vaccination improves effectiveness of cancer treatment, study finds

COVID vaccination improves effectiveness of cancer treatment, study finds

byUniversity of BonnNasopharyngeal tumors (highlighted in yellow) - are a common condition in countries in Southeast Asia. However, concerns that the therapy might interact unfavorably with Covi
Oncology January 23,2024
COVID vaccination improves effectiveness of cancer treatment, study finds

COVID vaccination improves effectiveness of cancer treatment, study finds

byUniversity of BonnNasopharyngeal tumors (highlighted in yellow) - are a common condition in countries in Southeast Asia. However, concerns that the therapy might interact unfavorably with Covi
Oncology January 23,2024
Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

by Delthia Ricks , Medical XpressTherapeutic inhibition of VEGF binding to NRP2 activates anti-tumor immunity in a syngeneic model of prostate cancer that is resistant to aPD-L1 therapy. (A) Shown is
Oncology January 23,2024
Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

by Delthia Ricks , Medical XpressTherapeutic inhibition of VEGF binding to NRP2 activates anti-tumor immunity in a syngeneic model of prostate cancer that is resistant to aPD-L1 therapy. (A) Shown is
Oncology January 23,2024
Study finds use of methotrexate is associated with an increased risk of skin cancer

Study finds use of methotrexate is associated with an increased risk of skin cancer

byUniversity of GothenburgRisk of basal cell carcinoma, cutaneous squamous cell carcinoma, and cutaneous malignant melanoma according to cumulative methotrexate dose for all patients. BCC basal
Oncology January 23,2024
Study finds use of methotrexate is associated with an increased risk of skin cancer

Study finds use of methotrexate is associated with an increased risk of skin cancer

byUniversity of GothenburgRisk of basal cell carcinoma, cutaneous squamous cell carcinoma, and cutaneous malignant melanoma according to cumulative methotrexate dose for all patients. BCC basal
Oncology January 23,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com